Journal Basic Info

  • Impact Factor: 1.809**
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Inflammation
  •  Endoscopy
  •  Otolaryngology
  •  Anatomy
  •  Diabetology
  •  Geriatric Medicine
  •  Veterinary Sciences
  •  Nutrition and Food Science


Citation: Ann Clin Case Rep. 2022;7(1):2226.DOI: 10.25107/2474-1655.2226

A Drug-Free, Digital, Self-Management Tool for Chronic Pain Patients Powered by Artificial Intelligence – A Pilot Trial

Gregory R Polston1, Maria Klement2, Ulrika Axelsson3, Mattias Olsson4, Göran Barkfors2 and Carl AK Borrebaeck2*

1Koman Family Outpatient Pavilion, UCSD Health Science Center, USA 2Department of Immunotechnology, CREATE Health Cancer Center, Lund University, Sweden 3Pain Drainer AB, Scheeletorget 1, Sweden 4Department of Theoretical Physics, Lund University, Sweden

*Correspondance to: Carl AK Borrebaeck 

 PDF  Full Text Commentary | Open Access


We describe the design and clinical utility of a digital tool aimed to increase the quality of life for chronic pain patients. PainDrainer is a drug-free, self-management tool, powered by artificial intelligence that adapts to the self-reported activities of each individual patient, resulting in a truly patient-centric support. The tool was tested in an open label, one-arm pilot study performed in two phases, encompassing in total 15 patients. The change in quality of life, pre-and post-treatment by using PainDrainer, was measured using a PROMIS Pain Interference 6a validated questionnaire. The outcome showed a statistically significant improvement in pain interference, surpassed the minimal important difference between T-scores, and showed a reduction in pain intensity after six weeks’ treatment. In conclusions the study showed both patient acceptance and improvement in quality of life for chronic pain patients.


Cite the Article:

Polston GR, Klement M, Axelsson U, Olsson M, Barkfors G, Borrebaeck CAK. A Drug-Free, Digital, Self- Management Tool for Chronic Pain Patients Powered by Artificial Intelligence – A Pilot Trial. Ann Clin Case Rep. 2022; 7: 2226..

Search Our Journal

Journal Indexed In

Articles in PubMed

Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II
 PubMed  PMC  PDF  Full Text
Does Autoimmunity have a Role in Myoclonic Astatic Epilepsy? A Case Report of Voltage Gated Potassium Channel Mediated Seizures
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Development and Validation of a Nomogram for Predicting Bladder Calculi Risk in Patients with Benign Prostatic Hyperplasia
 Abstract  PDF  Full Text
A Deletion of SGCE Gene in a Chinese Family with Myoclonus-Dystonia Syndrome
 Abstract  PDF  Full Text
View More...